AUG 13, 2019 09:21 AM PDT

Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease

WRITTEN BY: Dena Aruta

In healthy people, the blood-brain barrier (BBB), which is formed by brain endothelial cells, strictly controls the entrance of harmful materials into the brain and prevents anything toxic from crossing over. In addition, it regulates the clearance of β‐amyloid (Aβ) peptides, which are found in the brains of Alzheimer's patients. Impairment of the BBB is an important factor in many neurological diseases including Alzheimer's disease (AD). The breakdown of the BBB is present even before symptoms of cognitive decline and pathological changes are seen. 

Since the dysfunction of the BBB is believed to be a key component in the development of AD, there is enormous interest in creating cell-based models that imitate the same changes in the BBB seen in AD. Classic in vitro cell models have given greater insight into the pathological processes involved in AD and have helped in the discovery of new drugs to treat it. However, these models are of limited use because they lack many features of the BBB. Researchers at MIT have developed a "physiologically relevant 3D human neural cell culture microfluidic model" to study the role that blood vessels in the cerebrum play in AD.

The researchers created a 3D AD model that can perform numerous functions the in vitro BBB models cannot. These include: (1) a 3D microenvironment for cells to quantitatively evaluate BBB permeability, (2) integration of multiple steps into one experimental platform, (3) enhances quality of imaging studies and reduces reagent and tissue sample sizes, (4) the method supports different culture conditions and maturation periods of ReN cells (neural precursor cells) and the brain endothelial cells, and (5) provides an area for gradual accumulation of Aβs by allowing AD cells to continuously release Aβ, which slowly collects in and diffuses into the extracellular matrix.

"We were able to show clearly in this model that the amyloid-beta secreted by Alzheimer's disease cells can actually impair barrier function, and once that is impaired, factors are secreted into the brain tissue that can have adverse effects on neuron health," says Roger Kamm, the Cecil and Ida Green Distinguished Professor of Mechanical and Biological Engineering at MIT.

In order to demonstrate the impact a dysfunctional BBB has on AD pathogenesis, Shin and colleagues introduced the neurotoxic molecule, thrombin, the major enzyme involved in the coagulation system, into the 3D Ad model. It was able to pass through the BBB and caused neuronal death, but when etodolac, an NSAID drug, was applied to the membranes, thrombin was prevented from crossing the BBB. Another drug, beclomethasone, was also tried but did not decrease the BBB permeability as etodolac did.

"We're starting to use this platform to screen for drugs that have come out of very simple single cell screens that we now need to validate in a more complex system," Kamm says. "This approach could offer a new potential form of Alzheimer's treatment, especially given the fact that so few treatments have been demonstrated to be effective."

The original paper was published in Advanced Science on August 12, 2019.

 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
AUG 19, 2019
Cell & Molecular Biology
AUG 19, 2019
Revealing More About Aging on the Cellular Level
Our bodies are made up of trillions and cells, and millions of them die every day....
AUG 19, 2019
Cancer
AUG 19, 2019
Understanding aging: new research
We all do it every day, but there’s still so much we don’t understand about it. I’m talking about aging. But now new research published r...
AUG 19, 2019
Cell & Molecular Biology
AUG 19, 2019
The Rise of Drug Resistance Among Malaria Parasites
Around 220 million people get malaria every year after being bitten by a mosquito infected with the parasite that causes the disease....
AUG 19, 2019
Health & Medicine
AUG 19, 2019
Gene Linked To Cannabis Abuse
Research shows that there may be a specific gene associated with a higher risk of cannabis abuse. The same gene is responsible for the so-called nicotine r...
AUG 19, 2019
Chemistry & Physics
AUG 19, 2019
Chemists Synthesized Effective Antidote For Uranium Poisoning
Uranium poisoning is unusual to the general population but does happen to miners, mineral mill and fabrication workers. Through inhaling and ingestion, ura...
AUG 19, 2019
Drug Discovery
AUG 19, 2019
MDMA Treats Social Anxiety in Autistic Adults
People with autism are more likely than those without to develop social anxiety (Bejerot: 2014). Meanwhile, current anti-anxiety medications and therapeuti...
Loading Comments...